Table 1.
Total, n = 138
|
Primary, n = 89
|
|||
---|---|---|---|---|
n | % | n | % | |
Gender | ||||
Female | 86 | 62 | 53 | 60 |
Male | 52 | 38 | 36 | 40 |
Age, years (median, range) | 32 (0.2 to 78) | 33 (1 to 78) | ||
Site | ||||
Superficial trunk | 54 | 39 | 33 | 37 |
Extremity | 53 | 38 | 31 | 35 |
Deep trunk/mesentery | 18 | 13 | 14 | 16 |
Head and neck | 13 | 10 | 11 | 12 |
Size, cm (median, range) (total) | 6 (1.1 to 30) | (n = 108) | 6.8 (1.1 to 30) | (n = 76) |
Clinical data for the desmoid cohort. There were 138 desmoid patients with sufficient clinical and molecular data for analysis. The entire cohort of 138 was used for the analysis of clinical variables associated with CTNNB1 mutation genotype. The 89 patients with primary desmoid tumors on the array were used for the β-catenin immunohistochemical study.